ILF3 and colorectal cancer: In colorectal cancer, circPHLPP2 enhances interleukin-36 gamma (IL36γ) transcription via interleukin enhancer binding factor 3 (ILF3), suppressing natural killer (NK) cell infiltration and effector function, promoting anti-PD-1 resistance [168].